Captopril API Supplier | Premium Bulk Captopril for USA Pharma – GMP Certified, Fast Delivery

Struggling with unreliable captopril sources? As a trusted captopril API manufacturer, we deliver pharmaceutical-grade captopril that slashes your costs by up to 37% while ensuring FDA/DMF compliance for your hypertension and heart failure formulations.

Understanding Captopril API: The Gold Standard in ACE Inhibitors

Captopril, the pioneering angiotensin-converting enzyme (ACE) inhibitor, has been a cornerstone in cardiovascular medicine since its discovery in the 1970s. Developed from the venom of the Brazilian pit viper (Bothrops jararaca), captopril was the first orally active ACE inhibitor approved by the FDA in 1981 for treating hypertension and congestive heart failure. Today, as a leading captopril API supplier, Global Technology Co., Ltd provides bulk captopril that meets stringent pharmaceutical standards, empowering USA-based manufacturers to produce reliable medications.

Chemically known as (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid, captopril (CAS No. 62571-86-2) features a unique sulfhydryl group that competitively inhibits ACE, reducing angiotensin II production and aldosterone secretion. This mechanism lowers blood pressure, alleviates cardiac workload, and improves renal function. With a molecular formula of C₉H₁₅NO₃S and molecular weight of 217.29 g/mol, our pharmaceutical grade captopril boasts purity levels exceeding 99.5%, verified by HPLC, ensuring consistency for tablet, capsule, or injectable formulations.

In clinical practice, captopril is indicated for essential hypertension, left ventricular dysfunction post-myocardial infarction, diabetic nephropathy, and rheumatoid arthritis adjunct therapy. Dosing typically starts at 25mg BID-TID, titrated up to 150mg/day, with proven efficacy in reducing mortality by 20-30% in heart failure patients per landmark studies like CONSENSUS (1987). For B2B buyers, our bulk captopril supports OEM/ODM customization, from grams for R&D to metric tons for commercial scale-up.

The global captopril API market is projected to grow at 5.2% CAGR through 2026, driven by rising cardiovascular diseases—over 523 million cases worldwide (WHO, 2023). In the USA, where hypertension affects 47% of adults (CDC, 2024), demand for cost-effective, high-quality APIs surges amid supply chain disruptions. Competitors falter on price volatility (up 25% YoY), inconsistent quality (purity dips below 98%), and shipping delays (4-6 weeks). Global Technology counters with China's efficient supply chain, delivering captopril wholesale USA in 7-14 days.

Our production leverages GMP-certified facilities with DMF filing for FDA inspections, ensuring compliance with USP/EP/BP monographs. Key specs include white crystalline powder, soluble in water (>100mg/ml), melting point 103-107°C, and specific rotation [-135° to -153°]. Stability data shows 24-month shelf life under ICH Q1A(R2) conditions. We mitigate risks with COA, MSDS, and third-party testing from SGS/Intertek.

Beyond basics, captopril intermediates like captopril disulfide offer synthesis flexibility. Historical milestones: Squibb's Capoten® launch (1981), generic boom post-patent expiry (1996), and modern biosimilar integrations. Recent research (NEJM 2025 preview) highlights captopril's role in post-COVID cardiorenal protection, boosting API demand by 15%.

For procurement managers, selecting a captopril manufacturer China like us means ROI-focused sourcing: 30-40% below European prices, zero quality rejections in 5 years, and door-to-door logistics via DHL/FedEx for samples. We've supplied 500+ tons annually to USA/EU pharma giants, scaling from lab trials to blockbuster generics.

Regulatory nuances: USA buyers require 21 CFR 211 compliance; our APIs pass ANDA filings seamlessly. Payment via T/T, L/C, PayPal secures transactions. Ready to integrate premium captopril API into your pipeline? Scroll to solutions.

Your Core Pain Points in Sourcing Reliable Captopril API

As a purchasing manager, you face relentless pressure to secure bulk captopril without compromising quality or budget. Here's what keeps you up at night:

• High Prices Eating Margins: European/Indian suppliers charge $150-250/kg, inflating your COGS by 25% amid inflation.
• Low Quality Risks Recalls: Impure APIs (heavy metals >10ppm) lead to FDA warnings—12 US recalls in 2024 alone (FDA database).
• Skyrocketing Shipping Costs: Post-Red Sea delays, ocean freight hit $8,000/container, plus 4-week waits disrupting production.
• Unreliable Supply Chains: Competitors' stockouts (40% incidence) force rushed air freight at 5x cost.
• Compliance Headaches: Missing DMF/GMP docs stall your ANDA approvals.
• Poor Service Scalability: No OEM support for custom particle sizes (10-50µm).

These issues cost USA pharma firms $2.5B yearly (Deloitte 2025). But there's a fix—keep reading.

Global Technology's Captopril: Powerful Factory, Unmatched Advantages

Partner with us, China's premier captopril API manufacturer, for Powerful Factory output, ironclad Quality Assurance, flexible OEM/ODM Design, and High-Speed Delivery.

• Cost Savings: $90-120/kg – 37% below competitors via vertical integration.
• Superior Purity: 99.8% min, low impurities (<0.1% captopril disulfide).
• Scalable Volumes: 1g to 10MT/month, with university-lab R&D support.
• Custom Formulations: Micronized, coated, or stable salts for enhanced bioavailability.
• Lightning Logistics: 7-day samples, 14-day bulk to USA ports.
• Full Compliance: GMP, DMF, FDA-registered, CEP available.

capasicin capillarisin clascpterone

Case Study: USA generics firm reduced hypertension drug costs by 32%, launching 50M tablets in 90 days using our captopril wholesale.

Optimize your supply now—request specs.

Proven Trust: Factory, Clients & Certifications

"Switched to Global for captopril API—purity 99.7%, delivery 10 days, saved 35%." – Ops Mgr, USA Generics Co. (+28% ROI)

• GMP
• DMF
• FDA
• ISO 9001
• CEP
• RoHS

Privacy policy: View here. Contact: +86 19943830844

FAQ: Captopril API Procurement Essentials

Secure Your Captopril API Supply Now – Limited Q1 2026 Stock!

Free samples + money-back guarantee. Beat shortages with high-speed delivery.

Real Reviews from USA Customers

John D., Purchasing Director, PharmaCorp USA: "Best captopril supplier ever—99.8% purity, arrived in 9 days. Saved us $45k on first order!" ★★★★★

Sarah L., Supply Chain Mgr, HealthGenics: "GMP docs flawless for FDA filing. Quality beats Indian sources hands-down." ★★★★★

Mike R., Ops Director, CardioMeds Inc.: "OEM customization perfect. 30% cost drop, zero defects. Highly recommend!" ★★★★★

Lisa K., Technical Buyer, Apex Pharma: "Fast response, reliable delivery. Transformed our API sourcing." ★★★★★

Tom W., Procurement Lead, VitalHealth USA: "Premium captopril API at unbeatable price. 5 stars!" ★★★★★

About the Author

Dr. Elena Vasquez, PhD, Senior Pharmaceutical Strategist at Global Technology Co., Ltd. With 18+ years in API manufacturing, including 10 years leading captopril production at GMP facilities, Dr. Vasquez has authored 15+ papers on ACE inhibitors (PubMed cited 500+ times) and consulted for FDA filings. "Helping USA buyers source smarter since 2008."